AI drug discovery startup latest to go public via $2.8B SPAC merger

Retrieved on: 2021-06-14 04:52:30

Tags for this article:

Click the tags to see associated articles and topics

AI drug discovery startup latest to go public via $2.8B SPAC merger. View article details on hiswai:

Excerpt

AI drug discovery startup Valo announced it's going public via a $2.8 billion SPAC merger with Khosla Ventures, expected to close in Q3 2021.

Article found on: www.emarketer.com